NM_174858.3(AK5):c.360G>A (p.Glu120=) AND not provided

This record was updated by the submitter. Please see the current version.

Germline classification:: Likely benign (1 submission)
Last evaluated:: Mar 1, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003406565.8

Allele description

NM_174858.3(AK5):c.360G>A (p.Glu120=)

Gene:

AK5:adenylate kinase 5 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

1p31.1

Genomic location:

Preferred name:

NM_174858.3(AK5):c.360G>A (p.Glu120=)

HGVS:

NC_000001.11:g.77293905G>A
NM_012093.4:c.282G>A
NM_174858.3:c.360G>AMANE SELECT
NP_036225.2:p.Glu94=
NP_777283.1:p.Glu120=
NC_000001.10:g.77759590G>A

Molecular consequence:

NM_012093.4:c.282G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_174858.3:c.360G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Observations:

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

signaling lymphocytic activation molecule [Ictidomys tridecemlineatus]
signaling lymphocytic activation molecule [Ictidomys tridecemlineatus]
gi|532109406|ref|XP_005339418.1|

Protein
RecName: Full=Protransforming growth factor alpha; Contains: RecName: Full=Trans...
RecName: Full=Protransforming growth factor alpha; Contains: RecName: Full=Transforming growth factor alpha; Short=TGF-alpha; AltName: Full=EGF-like TGF; Short=ETGF; AltName: Full=TGF type 1; Flags: Precursor
gi|1351229|sp|P48030.1|TGFA_MOUSE

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004128275	CeGaT Center for Human Genetics Tuebingen	criteria provided, single submitter (CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)	Likely benign (Mar 1, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004128275

CeGaT Center for Human Genetics Tuebingen

criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)

Likely benign
(Mar 1, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	1	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From CeGaT Center for Human Genetics Tuebingen, SCV004128275.8

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	not provided

Description

AK5: BP4, BP7

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Aug 4, 2024

ClinVar

Relating variation to medicine